Maf b-Zip transcription factors are involved in both terminal differentiation and oncogenesis. To investigate this apparent contradiction, we used two different primary cell types and performed an extensive analysis of transformation parameters induced by Maf proteins. We show that MafA and c-Maf are potent oncogenes in chicken embryo fibroblasts, while MafB appears weaker. We also provide the first evidence that MafA can confer growth factor independence and promote cell division at low density. Moreover, using MafA as a model, we identified several parameters that are critical for Maf transforming activities. Indeed, MafA ability to induce anchorage-independent cell growth was sensitive to culture conditions. In addition, the transforming activity of MafA was dependent on its phosphorylation state, since mutation on Ser65 impaired its ability to induce growth at low density and anchorage-independent growth. We next examined transforming activity of large Maf proteins in embryonic neuroretina cells, where they are known to induce differentiation. Unlike v-Jun, MafA, MafB and cMaf did not show oncogenic activity in these cells. Moreover, they counteracted transformation induced by constitutive activation of the Ras/Raf/MEK pathway. Taken together, our results show that Maf proteins could display antagonistic functions in oncogenesis depending on the cellular context, and support a dual role for Maf as both oncogenes and tumor suppressor-like proteins.
Introduction
Maf proteins are b-Zip transcription factors belonging to the AP-1 superfamily. Members of this family are characterized by the presence of a bifunctional DNAbinding domain, composed of both a basic domain that contacts directly DNA, and a leucine zipper motif that allows dimerization and is absolutely required for DNA binding (Chinenov and Kerppola, 2001; Vinson et al., 2002) . The Maf family is composed of seven members, subdivided in two subfamilies, the large and the small Maf. The small Maf, MafF, MafG and MafK contain the b-Zip region but lack the transactivation domain (TAD) and, as homodimers, repress gene expression. Despite the absence of TAD, the small Maf can also activate transcription because of their ability to heterodimerize with other b-Zip proteins containing a TAD (Motohashi et al., 2002) . Four large Maf have been characterized in vertebrates: MafA/L-Maf, MafB/kreisler, c-Maf and Nrl, although the latter has not been found in avians (Nishizawa et al., 1989; Swaroop et al., 1992; Cordes and Barsh, 1994; Kataoka et al., 1994; Benkhelifa et al., 1998; Ogino and Yasuda, 1998; Lecoin et al., 2004) . In contrast to small Maf, these proteins contain an acidic TAD in their amino-terminal part. Maf proteins activate transcription of target genes through their binding to a DNA element, called MARE (Maf responsive element), which is related to TRE or CRE AP-1 sites (Motohashi et al., 2002) .
Most of Maf target genes identified so far, such as QR1, L7, crystallins, IL4, Hoxa3 and Hoxb3, are involved in differentiation (Cordes and Barsh, 1994; Kurschner and Morgan, 1995; Pouponnot et al., 1995; Ho et al., 1996; Ogino and Yasuda, 1998; Kim et al., 1999a, b; Manzanares et al., 1999) . However, several Maf target genes were found implicated during oncogenic processes, including cyclin D2, integrin b7 and p53 (Hale et al., 2000; Hurt et al., 2004) . Therefore, Maf proteins are involved in a variety of biological processes, such as oncogenesis and development/differentiation. Indeed, knockout studies in mice established a role for Maf proteins during development and differentiation in several organs or cell lineages, such as the hindbrain and preBo¨tC neurons for MafB (Cordes and Barsh, 1994; Blanchi et al., 2003) , the lens (Kawauchi et al., 1999; Kim et al., 1999b; Ring et al., 2000) and the T-cell TH2 lineage for c-Maf (Kim et al., 1999a) , and during hematopoiesis in the case of small Maf (Onodera et al., 2000) . Recent data obtained in chicken and mammals showed that large Maf are expressed in the developing pancreas and that MafA is involved in glucose-mediated insulin expression (Olbrot et al., 2002; Kataoka et al., 2002; Matsuoka et al., 2004; Lecoin et al., 2004) . In addition, MafA/L-Maf was proposed to be a master gene of lens development since its ectopic expression in chicken head ectoderm induced ectopic lens gene expression, such as crystallins (Ogino and Yasuda, 1998) . Like other b-Zip transcription factors, Maf activity is controlled at the post-translational level. We and others reported that large Maf are phosphorylated (Benkhelifa et al., 2001; Swain et al., 2001; Ochi et al., 2003) . We identified MafA serine residues 14 and 65 as essential targets for post-translational modification and showed that mutations preventing their phosphorylation (S14A and/or S65A mutations) decrease both MafA transcriptional activity and its ability to induce crystallin gene expression in cell culture (Benkhelifa et al., 2001) .
The involvement of Maf proteins in oncogenesis was first illustrated by identifying the founding member of this family, the v-maf oncogene, transduced in the genome of avian retrovirus AS42, that induces musculoaponeurotic fibrosarcoma in chicken (Nishizawa et al., 1989) . Accordingly, large but not small Maf were shown to transform chicken embryo fibroblasts (CEF) (Kataoka et al., 1994; Nishizawa et al., 2003) . In human, c-maf and mafB genes are rearranged in 5-10% of multiple myelomas. These translocations lead to Maf overexpression, possibly as a result of enhancer effects (Kuehl and Bergsagel, 2002; Boersma-Vreugdenhil et al., 2004; Hideshima et al., 2004) . Moreover, about 50% of multiple myelomas were recently found to overexpress c-Maf, even in the absence of chromosomal translocation, through a mechanism that remains to be characterized (Hurt et al., 2004) . c-maf overexpression in myeloma cells was responsible for tumor formation in immunodeficient mice and promotion of interaction between tumor and stroma cells (Hurt et al., 2004) . However, even though the role of Maf proteins in oncogenic processes seems firmly established, it appears somewhat contradictory with their involvement during terminal differentiation. For example, c-maf knockout mice show abnormal proliferation in the lens (Ring et al., 2000; Yoshida et al., 2001) and it was proposed that c-Maf is required for maintaining cell quiescence in this tissue. Some observations appear even more conflicting. Thus, the ability of large Maf to induce anchorage-independent growth in CEF was not systematically observed (Van Dam and Castellazzi, 2001 ). In addition, c-Maf expression was found repressed in human prostate cancers as compared to normal tissue, leading the authors to propose c-maf as a candidate tumor suppressor gene in this tumor (Watson et al., 2004) . In agreement with a putative role as tumor suppressor, it has been shown that Maf proteins could induce p53 transcription, thereby inducing a p53-dependent cell death (Hale et al., 2000) .
Owing to these conflicting results, we investigated the oncogenic properties of Maf proteins using two different primary cell cultures, chicken embryo fibroblasts (CEF) and neuroretina cells (NR). Our data showed that Maf proteins exhibit strong oncogenic capacity in CEF that is highly context dependent since it can be influenced by culture conditions as well as phosphorylation. This could account for the existence of contradictory reports with respect to Maf transforming activities. In NR cells where Maf proteins induce differentiation programs (Ogino and Yasuda, 1998; Mears et al., 2001 ), we did not observe oncogenic activity. Moreover, Maf counteracted RasV12 and its downstream effectors B-Raf and MEK transforming activities in these cells. Overexpression of c-Jun overcame this inhibition.
Taken together, our results support the notion that Maf proteins may function either as potent oncogenes or as proteins with tumor suppressor-like activity, depending on the cell context.
Results
MafA is a potent inducer of cell transformation in CEF To assess the transforming potential of MafA, we compared its ability to induce several transformation parameters with that of v-Jun, the best-characterized oncogene of the AP-1 superfamily. We used replicationcompetent retroviral constructs (Rcas) to express both proteins in CEF. Transfected cells were cultured for 10-15 days in order to ensure infection of all cells and efficient expression of the transgene ( Figure 1a) . As previously described, v-Jun overexpression lead to a decrease of endogenous c-Jun expression (Hussain et al., 1998; Chamboredon et al., 2003) . Distinct cell morphologies were observed in cultures expressing either v-Jun or MafA as compared to control Rcas culture (Figure 1b ). Cells expressing MafA displayed an elongated and fusiform shape. MafA activity was assayed in these cultures by transfecting a reporter plasmid containing the luciferase gene under the control of four copies of the Maf responsive element of the QR1 gene promoter (4xAbox-Tk-Luc). As previously described in other cell systems (Pouponnot et al., 1995; Benkhelifa et al., 1998; Benkhelifa et al., 2001) , MafA efficiently transactivated this reporter (Figure 1c ). In contrast, v-Jun did not transactivate this reporter which does not contain a TRE sequence, but instead repressed its transcription through a presently unknown mechanism ( Figure 1c ). These cultures were further used to investigate different cell transformation parameters induced by MafA.
Initially, we investigated the ability of MafA to allow cells to grow at high or low density (Figure 2a and b) . Cells were seeded at high density and cultures were allowed to reach confluency. Focus formation was revealed by staining with crystal violet. MafA expressing CEF formed numerous foci at high density. In contrast to control cultures, they were able to pile up in a crisscross pattern, indicating that they were not sensitive to contact inhibition (Figure 2a ). It is noteworthy that this phenotype was much more potently induced by MafA than v-Jun. Infected cells were also seeded at very low density (2500 cells per 100 mm dish) and cultures were grown for 15 additional days before cell colony formation was visualized by crystal violet staining (Figure 2b) . In contrast to control cultures, CEF expressing either v-Jun or MafA gave rise to large and dense foci. Thus, like v-Jun, MafA is able to induce cell growth at low density. Growth curve analysis of these cultures either in rich medium (5% fetal calf serum (FCS), 5% new born calf serum (NBCS) and 1% chicken serum) or in low serum condition (0.6% FCS) indicated that CEF expressing MafA divided at a higher rate than the control culture under both conditions Figure 1 . Cells were seeded at 2.5 Â 10 6 in 60 mm dishes and confluent cultures were grown for a week. Foci were visualized by crystal violet staining (top) and criss-cross formation was illustrated on phase contrast photographs (bottom). (b) Growth at low density. In all, 2500 cells of each culture were plated in 100 mm dishes. Cell growth was visualized 2 weeks later, by crystal violet staining (top) and cell number was counted in two duplicates (bottom). (c) Growth curves of the different cultures in high serum (5% FCS, 5% NBCS, 1% chicken serum) or low serum (0.6%FCS, 10% TBP). Medium was renewed every 2 days and cells were counted. (d) The apoptotic index and the number of cells in S phase in each culture have been determined in both high and low serum conditions using a tunnel assay and BrdU labeling, respectively, as indicated. (e) The presence of active hypophosphorylated (pRb) or inactivated hyperphosphorylated (ppRb) forms of the Rb protein was analysed by Western blotting with an anti-Rb antibody.
Dual role for Maf in oncogenesis C Pouponnot et al ( Figure 2c ). Therefore, like v-Jun, MafA ectopic expression in CEF enhanced their proliferative capacity in presence or absence of growth factors. This could result from either a decrease in apoptosis or an increase in cell division. In high serum condition, almost no apoptosis was detected by a tunnel assay in the three cultures ( Figure 2d) . A low apoptotic index (4.5%) was measured in control cells in low serum condition. This was decreased in MafA (2.5%)-and v-Jun (2.1%) expressing cells (Figure 2d ). BrdU labelling showed an increase in cell division in MafA and v-Jun cultures as compared to the control Rcas culture in both serum conditions ( Figure 2d ). A two-fold raise in S-phase cells was observed in low serum. Accordingly, the Rb protein was hypophosphorylated in control cells and inactivated in v-Jun and MafA cultures, as revealed by the appearance of its hyperphosphorylated forms (ppRb) (Figure 2e ). Since the apoptotic index remained low, it is likely that the increase in cell proliferation induced by MafA was mainly due to an acceleration of the cell cycle.
Owing to the contradictory data in the literature regarding the ability of MafA to induce colony formation in soft agar, we decided to test this activity using two different culture media (Figure 3 ). In contrast to control cultures, CEF expressing MafA formed numerous and large foci when cultured in DMEM medium, demonstrating the ability of MafA to induce anchorage-independent growth. However, only microscopic colonies were observed when MafA cells were cultured in F10-Ham medium, while v-Jun-expressing CEF grew as large colonies in this medium. Therefore the ability of MafA to induce anchorage-independent growth appears dependent on culture conditions since DMEM is enriched in several components as compared to F10-Ham. In conclusion, we showed that MafA efficiently induced all cell transformation parameters tested, including growth factor and anchorage-independent growth. Therefore, MafA displayed a strong oncogenic potential in CEF, comparable to that of v-Jun.
MafA phosphorylation increases its transforming ability
We previously reported that MafA differentiating activity depends on phosphorylation and we identified two major sites, serine14 and serine 65, whose mutation affected this activity. To assess whether phosphorylation of these two residues was also important for MafA transforming activity, we transfected CEF with Rcas constructs encoding MafA mutants carrying a serine to alanine substitution on each or both residues (S14A, S65A and S14/65A mutants). Western blot analysis showed that all MafA proteins were efficiently expressed ( Figure 4a ). As previously reported, the S14A mutant migrated slightly faster than the wild-type (WT) protein, whereas the S65A and S14/65A mutants migrated much faster (Benkhelifa et al., 2001) . These results indicated that serine residues 14 and 65 of the WT MafA protein were also phosphorylated in CEF. As shown in other cell systems (Benkhelifa et al., 2001) , the transactivating potential of all three mutants was decreased, the double S14/65A and the single S65A mutants being most affected ( Figure 4b ). Using these cultures, we investigated the ability of MafA phosphorylation mutants to induce CEF growth at low or high density, and in soft agar.
When seeded at high density, cultures expressing either phosphorylation mutants were able to form foci (Figure 4c ), suggesting that the phosphorylation status of MafA is not essential for this activity. However, we noticed that the S14/65A mutant was slightly affected. In contrast, growth at low density was strongly impaired by mutation of MafA phosphorylation sites (Figure 4d) . Indeed, few and smaller colonies were observed in CEF expressing S65A and S14/65A mutants, the culture expressing the S14/65A mutant behaving as the control Rcas culture. When grown in soft agar, numerous and large colonies were observed in CEF expressing either the WT protein or the S14A mutant (Figure 4e ). In contrast, cultures expressing the S65A or S14/65A mutants formed only microscopic colonies. Thus, WT and S14A proteins efficiently induced anchorage-independent growth, whereas proteins mutated on serine 65 were strongly affected. This suggested that phosphorylation of serine 65 was required for MafA to exert full transforming capacity, although growth at high density seemed to be only moderately affected by mutation of this residue.
Comparison of MafA, c-Maf and MafB transforming activities in CEF We next compared the transforming ability of MafA to that of MafB and c-Maf in CEF, regarding all parameters described above. We also assessed the role of Maf transactivation and dimerization domains by generating two constructs encoding MafA proteins truncated in the N-terminal transactivation domain Figure 3 MafA-induced anchorage-independent growth depends on culture conditions. Rcas, v-Jun and MafA cells were cultured for 3 weeks in soft agar, either in F10-Ham medium or in DMEM medium, as indicated. Plates were scanned to visualize the macroscopic colonies and beside are shown phase contrast photographs illustrating the characteristic morphology of the colonies in each culture. Figure 5a ). However, we reproducibly observed reduced MafB protein accumulation as compared to cMaf or MafA. MafA, MafB and c-Maf were all able to induce luciferase activity from the 4 Â Abox-Tk-Luc construct, albeit with different efficiencies (Figure 5b ).
As expected, the two inactive mutants DNter and LZ did not transactivate this promoter. The nature of the target genes induced by Maf proteins during CEF transformation remains largely unknown. However, HB-EGF mRNA level was shown to be increased by the Q5H-activated mutant of v-Maf (Fu et al., 1999) . Reverse transcription (RT)-PCR analysis showed that MafA, MafB and c-Maf are all able to induce HB-EGF expression at comparable levels, despite the lower expression of MafB (Figure 5c ). Like the untagged protein, HA-tagged MafA induced foci formation at high density (Figure 5d ). This was also Dual role for Maf in oncogenesis C Pouponnot et al again the most potent. Finally, we tested all these proteins for their capacity to induce anchorage-independent growth. When grown in soft agar, cultures expressing MafA and c-Maf formed macroscopic colonies, whereas MafB induced only microscopic colonies (Figure 5f ). In conclusion, MafA, MafB and c-Maf proteins were all transforming in CEF but MafB, which was less expressed, appeared less potent in several activities. Importantly, all the transforming properties described above were severely impaired by mutation of the leucine zipper or truncation of the transactivation domain of MafA (Figure 5d , e and f), demonstrating that the ability of large Maf proteins to bind DNA and to transactivate their target genes was required for CEF transformation.
Maf proteins do not display oncogenic activity in primary cultures of neuroretina cells We further expanded our investigation of Maf oncogenic properties to another primary cell system in which these proteins are known to induce differentiation. As primary cultures of chicken embryonic neuroretina (NR) cells do no divide actively and are differentiating, one can assess the ability of an oncogene to overcome antiproliferative signals which take place during terminal differentiation (Papin et al., 1998; Peyssonnaux et al., 2000) . Therefore, NR cells dissected from 8-dayold chicken embryos were transfected with constructs expressing each of the Maf proteins and carrying a neomycin selection marker. Cultures were examined for the presence of foci of proliferating cells, 2 weeks after G418 selection (Figure 6a ). NR cultures transfected with control plasmid pcDNA3 contained only nondividing isolated cells, whereas NR cultures transfected with an expression vector for RasV12 contained numerous and large foci of dividing cells, as previously reported . V-Jun was as efficient as RasV12 in inducing NR cell proliferation (Figure 6a ), although cell morphology in proliferating colonies was very distinct (not shown). In sharp contrast with their mitogenic activity in CEF, however, HA-tagged MafA, MafB and c-Maf were unable to sustain NR cell division (Figure 6a ). Similar results were obtained with an untagged version of MafA (data not shown). Western blot analysis showed that HA-tagged proteins were efficiently expressed in transfected NR cultures (Figure 6b ), although MafB expression was again reduced as compared to that of MafA and c-Maf. In conclusion, in contrast to our observations in CEF, Maf proteins do not display oncogenic potential in retina, whereas v-Jun is a very potent oncogene in both systems. Maf proteins were previously shown to induce NR cell transdifferentiation. Indeed, overexpression of Maf in neuroretina induces expression of lens-specific genes such as d-crystallin (Ogino and Yasuda, 1998; Yoshida and Yasuda, 2002 ). Therefore, we tested whether Maf proteins were also able to induce d-crystallin expression in our assay. As shown in Figure 6b , strong d-crystallin induction was detected in cultures transfected with MafA, MafB and c-Maf, but not in cultures transfected with either empty pcDNA3 or constructs encoding RasV12 and v-Jun. We next investigated whether the differentiating potential of Maf proteins in NR cells could interfere with Ras-induced NR cell proliferation. The plasmid encoding RasV12 was cotransfected in NR cultures with either HA-tagged MafA, MafB, c-Maf or c-Jun as a control. As shown in Figure 7a , c-Jun markedly cooperated with RasV12 to induce large and numerous foci, in agreement with previous studies using other cell systems (Schutte et al., 1989; Smeal et al., 1991; Vandel et al., 1996) . In contrast, expression of MafA, MafB and c-Maf resulted in a marked decrease of the number of colonies induced by RasV12. This was not observed with the LZ and DNter MafA mutants, suggesting that this inhibition depends on Maf transactivation activity (Figure 7b ). Western blot analysis confirmed that Maf and Jun proteins were coexpressed with Ras ( Figure 7) .
We previously reported that NR cell transformation induced by Ras V12 is strongly dependent on the Raf/ MEK/ERK pathway . Therefore, we analysed the effect of MafA expression on NR cell proliferation induced by constitutively activated versions of specific components of this pathway . These results clearly showed that MafA counteracts Ras signaling at a step downstream of MEK. We also analysed the effect of MafA on NR cell proliferation induced by Jun, which is well known to play a critical role in the nuclear response triggered by Ras signaling (Lloyd et al., 1991; Johnson et al., 1996) . In contrast to Ras, Raf or MEK, the oncogenic properties of c-Jun and v-Jun were not inhibited by MafA. Moreover, Maf and Jun proteins cooperated to induce NR cell proliferation. Interestingly, overexpression of c-Jun was able to rescue the blockade of Ras by Maf (Figure 8b ). Taken together, these findings show that Maf interfere with the nuclear response of Ras signaling in NR cells.
Discussion
Maf proteins are involved essentially in two apparently contradictory processes: terminal differentiation and oncogenesis. The present study is the first to compare a large panel of transformation parameters, using two different cell types, and to correlate them with expression levels of large Maf proteins. We showed that MafA and c-Maf are potent oncogenes in CEF, while MafB The use of tagged versions of MafA, MafB and cMaf, together with the assessment of multiple transforming parameters in different cell systems, allowed us to compare rigorously the transforming activities of these proteins and to provide a rationale for the partial and sometime intriguing previous observations. For example, Nishizawa et al. (2003) concluded that MafB was the weakest oncogene among the three genes tested. While we confirmed that MafB was less potent than MafA and c-Maf in conferring anchorage-independent growth, we reproducibly observed, however, a reduced MafB protein accumulation as compared to MafA or c-Maf both in CEF and in NR cells. Similar lower expression of MafB was also observed in transfected NIH3T3 cells (Yoshida and Yasuda, 2002) . Therefore, it is conceivable that MafB protein is less stable than MafA and c-Maf, which may account for its weaker ability to induce growth in soft agar. However, in spite of its lower expression level, MafB efficiently induced cell growth at low density, suggesting that this activity requires lower Maf expression threshold. Likewise, MafB efficiently induced HB-EGF transcription. In conclusion, MafA and c-Maf display strong and rather similar oncogenic activities in CEF, while MafB appears as a weaker oncogene, likely because of a lower expression level.
Our study also provided evidence that the transforming activities of MafA were very sensitive to its phosphorylation state. Only one parameter tested, growth at high density, appeared to be rather insensitive to MafA phosphorylation since the S14A and S65A mutants were similar to the WT protein, although the double S14/65A mutant was slightly affected. In contrast, MafA ability to confer growth at low density as well as anchorage-independent growth was strongly impaired in the mutants carrying the S65A substitution. These results demonstrate that MafA transforming activity is markedly sensitive to phosphorylation, and that integrity of serine 65 is required for MafA oncogenic potential. Thus, our investigation of different transforming parameters led us to challenge recent observations (Nishizawa et al., 2003) . Thus, in their study, the authors found the S65A mutant much more active than the WT protein in inducing growth at high density, leading them to propose that phosphorylation of serine 65 inhibits the transforming activity of MafA. The reason for this discrepancy is unclear but in the absence of data regarding mutant protein expression and of other transformation parameters, no definitive conclusion could be drawn from their study. Since our results showed that phosphorylation of serine 65 enhances MafA oncogenic potential, inactivating the kinase responsible for MafA phosphorylation on residue S65 should decrease MafA oncogenic properties. As residue S65 is conserved in all large Maf proteins, this could represent an interesting therapeutic approach for the 50% of multiple myeloma in which these proteins are overexpressed.
Another interesting feature of Maf transforming activity revealed in our study is its dependence on culture conditions. Indeed, MafA efficiently induced anchorage-independent CEF growth in DMEM medium, whereas this activity was markedly decreased when nutrients concentration was reduced, such as in F10-Ham medium. We reasoned that a default in intracellular signaling, usually induced by culture conditions, could result in a lack of MafA serine 65 phosphorylation in Ham medium. However, we did not detect any change in MafA electrophoretic migration pattern in this medium (data not shown), suggesting that the absence of transforming activity is unlikely to be due to dephosphorylation of serine 65. The use of different culture conditions could explain the conflicting results reported by various groups regarding Maf ability to induce anchorage-independent growth in CEF (Kataoka et al., 1994; Van Dam and Castellazzi, 2001; Nishizawa et al., 2003) .
We also showed that Maf transforming activity is strikingly dependent on the cell type. While v-Jun proved to be a potent oncogene in both CEF and neuroretina (NR) cells, Maf transformed CEF but not NR cells. These primary cells do not divide actively and differentiate in culture. Therefore, in this system, Maf proteins were not transforming probably because they were not able to bypass growth arrest signals. In addition to their inability to sustain NR cell proliferation, Maf proteins induced a strong expression of dcrystallin, a differentiating lens gene. Taken together, these observations demonstrate that the biological response triggered by Maf proteins is strongly dependent on the cell type, the cell environment and their phosphorylation status.
Our work further highlights an ambivalent role of Maf proteins in oncogenesis. While several reports underlined Maf oncogenic potential (Kataoka et al., 1994; Nishizawa et al., 2003; Hurt et al., 2004) , c-Maf has been recently proposed as a candidate tumor suppressor gene in prostate cancer (Watson et al., 2004) . Our findings support such a dual role. On the one hand, Maf proteins displayed a strong but contextdependent transforming activity in CEF. On the other, Maf proteins not only failed to transform NR cells but also antagonized Ras oncogenic activity, supporting a tumor suppressor-like activity in this system. This activity requires Maf ability to induce gene expression and could be challenged by c-Jun overexpression, suggesting that Maf interfere with the nuclear response of the Ras/Raf/ERK pathway. Maf ability to initiate lens differentiation through the induction of d-crystallin
Dual role for Maf in oncogenesis C Pouponnot et al expression might be responsible for the inhibition of Ras-mediated proliferating foci formation. Interestingly, c-maf knockout mice showed abnormal proliferation in the posterior region of the lens (Ring et al., 2000; Yoshida et al., 2001) . Therefore, in tissues where they play a role in terminal differentiation such as lens, Maf proteins could maintain cell quiescence, whereas in other tissues, their oncogenic activity would prevail. Accordingly, abnormal c-Maf expression in normal lymphoid plasma cells where Maf are not usually expressed, results in multiple myeloma malignant progression. Conversely, MafB is expressed specifically in the myeloid lineage and its overexpression in transformed myeloblasts stimulates macrophage differentiation (Kelly et al., 2000) . This dual activity (tumor suppressor-like or oncogenic) of Maf is supported both by the present study and by data from the literature and becomes an emerging concept that could be extended to other oncoproteins. For example, Notch proteins that are involved in many developmental aspects can act either as oncogenes or as tumor suppressors depending on the tumor type (Radtke and Raj, 2003) . One can hypothesize that such a dual role could be a hallmark of proteins involved both in differentiation and oncogenesis.
Materials and methods

Plasmid construction
A consensus Kozak sequence and the HA1 epitope were introduced at the 5 0 and C-terminus, respectively, of avian MafA, MafB and the short form of c-Maf, c-MafII (Pouponnot et al., 1995; Benkhelifa et al., 2001) by PCR. The cDNAs were cloned into the pcDNA3 vector carrying the neomycin-resistance gene, using HindIII/BamHI (MafA and MafB) or HindIII/EcoRI (c-MafII). Avian v-Jun and human HA-tagged c-Jun were kindly provided by Marc Castellazzi and subcloned into the pcDNA3. The MafA phosphorylation mutants were generated by successive rounds of PCR (Benkhelifa et al., 1998) . The HA-tagged DNter and LZ MafA mutants were previously described (Benkhelifa et al., 1998) and subcloned into the pcDNA3. All the cDNAs were subsequently sequenced and cloned into the Rcas-A replicationcompetent retroviral vector using the Cla12 shuttling plasmid (Hughes et al., 1987) . The pcDNA3-derived constructs encoding untagged or HA1-tagged RasV12 were described previously (Busca et al., 2000; Peyssonnaux et al., 2000) . The plasmid encoding quail B-Raf fused to the Ki-Ras CAAX sequence (B-Raf CAAX ) was described previously (Papin et al., 1998) . The plasmid encoding constitutively activated rat MEK2 (MEK2 DD ) was a kind gift from Andrew D Catling (Catling et al., 1995) . The Rcas/v-Jun construct was a generous gift from Marc Castellazzi. The 4xAbox-Tk-luc reporter plasmid was constructed as follows: a SalI/BglII fragment from the previously described TK10-4 Â WT reporter carrying four copies of the À1208/À1161 region (Abox) of the QR1 promoter containing a Maf responsive element (Pouponnot et al., 1995) and the À109/ þ 55 fragment of the thymidine kinase promoter were inserted into the SmaI/BglII sites of the pGL2basic vector (Promega).
Cell culture and transfections CEF were prepared from 10-day-old O-line chicken embryos as previously described (Golde and Vigier, 1961) . They were routinely cultured in DMEM medium supplemented with 5% FCS, 5% NBCS and 1% chicken serum and 10% TPB. Cells were transfected in 100 mm dishes with 1 mg of Rcas-derived DNA constructs using Effectene transfection reagent (Qiagen) and grown for 15 days to allow virus propagation and to obtain a homogenous culture expressing the transgene.
Neuroretina (NR) cells from 8-day-old chicken embryos were prepared as previously described and cultured in BME supplemented with 10% FCS . They were transfected with pcDNA3-derived constructs by the phosphate calcium method as previously described (Pouponnot et al., 1995) .
Tunnel assay 1 Â 10 5 cells (regular medium condition) or 1.75 Â 10 5 cells (low serum condition) were seeded on a glass slide in 12-well dishes. After 1 day, cells were washed twice and cultured for 24 h. Cells were then fixed with 4% paraformaldehyde for 30 min. Slides were processed with the in situ cell death kit, AP (Roche) according to the manufacturer's instructions. Dapi-positive cells as well as apoptotic cells were counted.
BrdU labeling
In total, 100 000 cells (regular medium condition) or 175 000 cells (low serum condition) were seeded on a glass slide in 12-well dishes. After 1 day, cells were washed twice and cultured for 24 h. After a 4h-period of incorporation with 50 mM BrdU, cells were then fixed for 30 min with 4% paraformaldehyde, permeabilized in PBS-0.1% triton X-100 for 10 min, and blocked in PBS-20% FCS for 30 min. Slides were incubated for 1 h in a humid chamber in PBS-20% FCS containing the antiBrdU antibody (1/500) (Sigma) and 0.5 mg/ml of DNase1. They were washed three times with PBS, and incubated with the goat anti-mouse alexa594 Fluor secondary antibody (1/ 200) for 45 min. Slides were mounted and counterstained with Dapi. Dapi-and BrdU-positive cells were counted.
RNA preparation and RT-PCR analysis
Total RNA was prepared using the RNA Now extraction kit (Invitrogen). RT was carried out with 1 mg of total RNA by using the Promega reverse transcription system. PCR was performed on three different volumes (1, 2 and 4 ml) of firststrand cDNA with Taq DNA polymerase (Promega) in the presence of 200 mM deoxynucleoside triphosphate and 1 mM primers. Primer pairs, number of cycles and annealing temperatures were as follows: MafA (5 0 -CGCTTGGAGGA-GAGGTTTTCC and 5 0 -CTCCTTGGCCAAACGGGAAC; 26 cycles; 571C); MafB (5 0 -ACGCTCAGTCCTGCAGGTA-TA and 5 0 -GGCAAGTTTCTCACACTTGAG; 26 cycles; 531C); c-Maf (5'-TGCACTTCGACGACCGCTTCT and 5 0 -TTGTCGCTGCTGGATCCGTTT; 26 cycles; 531C); HB-EGF (5 0 -AGCGCTTGCTGTTGTCGCAG and 5 0 -GCTGCCTGACAAAGCCCCAAA; 26 cycles; 571C) and S17 (5 0 -TACACCCGTCTGGGCAACGAC and 5'-CCGCTGGATGCGCTTCATCAG; 26 cycles; 571C).
Cell transformation assays
To assess foci formation at high density, CEF were seeded at 2.5 Â 10 6 per 60 mm dish and cultured for an additional week in routine medium and then stained with 1.0% crystal violet in 20% ethanol. Colony formation at low density was assayed by seeding cells in quadruplicate at 2500 cells per 100 mm dish. Cells were grown for 2 weeks in routine medium and then two plates were stained with crystal violet while cells were counted in the two remaining plates. For growth curve analysis, cells were seeded at 1 Â 10 5 and cultured either in routine medium (high serum) or in DMEM supplemented with 0.6% FCS and 10% tryptose phosphate broth (TPB) (29.5 g/l-Sigma) (low serum). Two plates were counted at each time point. To assess anchorage-independent growth, CEF were suspended in agarcontaining medium at concentration of 1 Â 10 5 cells per 60 mm dish. Solid medium was either F10-Ham or DMEM, both containing 0.66% agarose, 10% TPB, 5% FCS, 5% NBCS and 1% chicken serum. Single-cell suspensions were prepared in the same medium containing 0.33% agarose. Plates were maintained at 371C for 2-3 weeks to allow colony formation.
Proliferating foci formation assays in NR cells were performed as previously described . Briefly, 3-5 days following transfection, G418 selection (0.6 mg/ml) was applied for 15 days. Foci of proliferating cells were then stained with 1.0% crystal violet (in 20% ethanol). Protein expression levels were assessed at the starting point of selection.
Luciferase assays CEF were seeded at 1 Â 10 5 cells per well in six-well plates and transfected with 1 mg of reporter constructs (4 Â Abox-Tk-Luc) and 0.1 mg of a b-actin/b-galactosidase-normalizing plasmid (Pouponnot et al., 1995) using Effectene transfection reagent (Qiagen). After 2 days, cellular extracts were prepared using the Reporter Lysis Buffer (Promega) and assayed for luciferase activity using the Luciferase Assay Reagent (Promega). Transfection efficiency was monitored by measuring bgalactosidase activity (Galacto-star-Tropix). Experiments were carried out in triplicate.
Western blot analysis
Cell extracts were submitted to 10% SDS-PAGE (polyacrylamide gel electrophoresis), transferred to Immobilon-P membranes (Millipore) and probed with a rabbit polyclonal antibody raised against a MafA peptide (1/5000) (Sii-Felice et al., 2005) , anti-Jun antibody (1/1000) (Upstate Biotechnologies Inc.), polyclonal anti-HA1 epitope (Y11) (1/1000) (Santa-Cruz), anti-Ras (1/500) (BD Biosciences), anti-Rb (1/ 250) (Pharmingen), anti-B-Raf (1/2000) (Santa-Cruz) or anti-MEK2 (1/1000) (Santa-Cruz). The antiserum directed against chicken d-crystallins was kindly provided by Joram Piatigorsky (Ostrer et al., 1981) and used at 1/4000. Membranes were revealed using chemiluminescence SuperSignal West Dura (Pierce).
